Researchers from University of Edinburgh Report Recent Findings in Bulimia (Pharmacotherapy of Anorexia Nervosa and Bulimia Nervosa Using Ssris, Maois and Tcas).

The article focuses on recent research from the University of Edinburgh regarding the pharmacotherapy of anorexia nervosa and bulimia nervosa, which are classified as eating disorders. It highlights that while psychotherapy is the primary treatment, pharmacotherapy options such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) can also be utilized. The research indicates that SSRIs are effective for bulimia nervosa but have limited efficacy for anorexia nervosa, which may require further investigation. Additionally, it notes that monoamine oxidase inhibitors (MAOIs) and certain TCAs may be beneficial for treatment-resistant cases of bulimia nervosa. The study emphasizes the importance of understanding various treatment options due to the high mortality rates associated with these disorders. [Extracted from the article]